Interplay of Mediterranean-diet adherence, genetic factors, and metabolic dysfunction-associated steatotic liver disease risk in Korea

被引:3
|
作者
Kwon, Yu-Jin [1 ]
Choi, Ja-Eun [2 ]
Hong, Kyung-Won [2 ]
Lee, Ji-Won [3 ,4 ]
机构
[1] Yonsei Univ, Coll Med, Yongin Severance Hosp, Dept Family Med, 363 Dongbaekjukjeon Daero, Yongin 16995, Gyeonggido, South Korea
[2] Theragen Hlth Co Ltd, Inst Adv Technol, Pangyoyeok Ro, Seongnam 13493, Gyeonggido, South Korea
[3] Yonsei Univ, Coll Med, Severance Hosp, Dept Family Med, Yonsei Ro 50-1, Seoul 03722, South Korea
[4] Yonsei Univ, Inst Innovat Digital Healthcare, Yonsei Ro 50-1, Seoul 03722, South Korea
基金
新加坡国家研究基金会;
关键词
Mediterranean diet; Metabolic dysfunction-associated fatty liver disease; Gene-diet interaction; Glucokinase regulatory protein gene; FATTY LIVER; TRIGLYCERIDE; VALIDATION; OBESITY; LOCI; GCKR;
D O I
10.1186/s12967-024-05408-z
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Backgrounds Metabolic dysfunction-associated steatotic liver disease (MASLD) has gained attention owing to its severe complications. This study aimed to explore the interaction between Mediterranean-diet (MD) adherence, genetic factors, and MASLD risk in a Korean population. Methods In total, 33,133 individuals aged 40 years and older from the Korean Genome and Epidemiology Study (KoGES) were analyzed. Participants were assessed for MASLD based on criteria and MD adherence measured by the Korean version of the Mediterranean-Diet Adherence Screener (K-MEDAS). Individuals were categorized into two groups based on their MD adherence: high adherence (K-MEDAS > 6) and low adherence (K-MEDAS < 5). Single nucleotide polymorphism (SNP) genotypes were obtained using the Korea Biobank array. Logistic regression was used to examine the single-marker variants for genetic associations with MASLD prevalence. Results Individuals were categorized into MASLD (10,018 [30.2%]) and non-MASLD (23,115 [69.8%]) groups. A significant interaction was observed between the rs780094 glucokinase regulatory protein (GCKR) gene and K-MEDAS on MASLD (p < 10(-2)). Of individuals with K-MEDAS > 6, those carrying the minor allele (C) of the GCKR gene rs780094 exhibited a lower risk of MASLD compared to those without the allele (odds ratio [OR] = 0.88 [0.85-0.91], p-value = 5.54e-13). Conclusion The study identified a significant interaction involving the rs780094 variant near the GCKR gene, with carriers of the minor allele exhibiting a lower MASLD risk among those adhering well to the MD. Dietary habits influence the MASLD risk associated with the rs780094 allele, emphasizing the need for personalized nutrition recommendations.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Menopause and metabolic dysfunction-associated steatotic liver disease
    Polyzos, Stergios A.
    Goulis, Dimitrios G.
    MATURITAS, 2024, 186
  • [22] Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
    Lee, Na Young
    Choi, Myeung Gi
    Lee, Eui Jin
    Koo, Ja Hyun
    ARCHIVES OF PHARMACAL RESEARCH, 2024, 47 (06) : 558 - 570
  • [23] Metabolic Dysfunction-Associated Steatotic Liver Disease and Polycystic Ovary Syndrome: A Complex Interplay
    Arvanitakis, Konstantinos
    Chatzikalil, Elena
    Kalopitas, Georgios
    Patoulias, Dimitrios
    Popovic, Djordje S.
    Metallidis, Symeon
    Kotsa, Kalliopi
    Germanidis, Georgios
    Koufakis, Theocharis
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (14)
  • [24] Insulin resistance and cardiovascular risk factors in childhood metabolic dysfunction-associated steatotic liver disease
    Gumus, Meltem
    Yorulmaz, Alaaddin
    Candan, Hakan
    Ergani, Anna Carina
    Kaya, Reyhan
    Bugrul, Fuat
    Vatansev, Huesamettin
    Emiroglu, Halil Haldun
    CUKUROVA MEDICAL JOURNAL, 2023, 48 (03): : 1115 - 1130
  • [25] Nutrients associated with metabolic dysfunction-associated steatotic liver disease
    Jeong, Seogsong
    JOURNAL OF HEPATOLOGY, 2024, 80 (02) : e81 - e82
  • [26] Are we ready for genetic testing in metabolic dysfunction-associated steatotic liver disease?
    Tulone, Adele
    Pennisi, Grazia
    Ciccioli, Carlo
    Infantino, Giuseppe
    La Mantia, Claudia
    Cannella, Roberto
    Mercurio, Francesco
    Petta, Salvatore
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2024, 12 (05) : 638 - 648
  • [27] From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
    Chen, Li
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (12) : 1253 - 1257
  • [28] Socioeconomic factors associated with the presence of and outcomes in metabolic dysfunction-associated steatotic liver disease
    Nasr, Patrik
    Shang, Ying
    Wester, Axel
    Strandberg, Rickard
    Widman, Linnea
    Lazarus, Jeffrey V.
    Hagstrom, Hannes
    LIVER INTERNATIONAL, 2024, 44 (11) : 3050 - 3059
  • [29] PROSPECTIVE VALIDATION OF THE MEDITERRANEAN DIET ADHERENCE SCREENER (MEDAS) FOR POINT-OF-CARE ASSESSMENT OF DIET QUALITY IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
    Byale, Anjali
    Yang, Zhe
    Chang, Catherine
    Lee, Hansol Olivia
    Wang, Renwei
    Luu, Hung
    Yuan, Jian-Min
    Behari, Jaideep
    HEPATOLOGY, 2024, 80 : S1956 - S1957
  • [30] Management of cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease
    Mellemkjaer, Anders
    Kjaer, Mikkel Breinholt
    Haldrup, David
    Gronbaek, Henning
    Thomsen, Karen Louise
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 : 28 - 34